Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Algoma Central Corp 5.25 Pct Debs (ALC-DB-A.TO)

Algoma Central Corp 5.25 Pct Debs (ALC-DB-A.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Algoma Central Corporation to Hold 2023 Annual General Meeting on May 3, 2023 Business Wire - Wed Apr 19, 2023

Algoma Central Corporation (TSX: ALC) (TSX: ALC.DB.A) is pleased to announce that the 2023 Annual General Meeting (“Meeting”) of Shareholders will be held in person on Wednesday May 3, 2023 at Canada...

ALC.TO : 14.95 (-1.32%)
ALC-DB-A.TO : 99.82 (-0.27%)
Algoma Central Corporation to Hold 2022 Annual General Meeting of Shareholders Virtually on May 4, 2022 Business Wire - Wed Apr 20, 2022

Algoma Central Corporation (TSX: ALC) (TSX: ALC.DB.A) is pleased to announce that the 2022 annual general meeting of shareholders will be held virtually via a live webcast available at www.virtualshareholdermeeting.com/ALC2022...

ALC.TO : 14.95 (-1.32%)
ALC-DB-A.TO : 99.82 (-0.27%)

Barchart Exclusives

Thanks to Wall Street, Novo Nordisk Stock is Now a Buy Barchart - Sat Nov 2, 10:15AM CDT
Novo Nordisk has lost about a quarter of its value since the end of June. Meanwhile, indications are that its diabetes and weight-loss drugs may be useful in fighting cardiovascular disease, arthritis, opioid and alcohol addiction, and Alzheimer's. Novo remains a leader in the sector, and is trading at a valuation a third cheaper than competitor, Eli Lilly. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot